Results 161 to 170 of about 51,995 (213)

Comparing the Influence of Heterogeneity on Model Outcomes in Individual-Level and Cohort Simulations: An Exploratory Simulation Study. [PDF]

Pharmacoeconomics
van Well EB, Govers TM, Koffijberg H.
europepmc   +1 more source

External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost Effectiveness. [PDF]

Pharmacoeconomics
Fawsitt CG, Thom H, Aceituno D, Jarde A, Larsen S, Lübker C, Kayongo E, Keeney E, Foos V.   +8 more
europepmc   +1 more source

Physician Perspectives on Pharmaceutical Promotion.

JAMA Health Forum
Mooney H, Austad K, Campbell EG, Avorn J, Lu Z, Kesselheim AS.   +5 more
europepmc   +1 more source

Medicare Part D Savings Under the Manufacturer Discount Program vs Coverage Gap Discounts.

JAMA Netw Open
Rome BN, Garrett KR, Maini L.
europepmc   +1 more source

Revenue Differences Between Top-Selling Small-Molecule Drugs and Biologics in Medicare.

JAMA Health Forum
Vogel M, Feldman WB, Cowan Z, Rome BN, Chandra A, Kesselheim AS, Wouters OJ.   +6 more
europepmc   +1 more source

Economic Regulation and Its Reform: What Have We Learned? [PDF]

Eric L. Keuffel, Patricia M. Danzon
core  

Translation and Cultural Adaptation of the Measure Yourself Concerns and Wellbeing (MYCaW) Questionnaire Into German: Protocol for the iSWOP Study.

JMIR Res Protoc
Thronicke A, Schille L, Adie K, Junghanss C, Oei SL, Johnson S, Roos J, Schad F.   +7 more
europepmc   +1 more source

Protocols for TTO valuations of health states worse than dead: A literature review and framework for systematic analysis [PDF]

Buckingham, K., Devlin, N., Tilling, C., Tsuchiya, A.   +3 more
core